Skip to main content
. 2019 Mar 4;16(3):e1002756. doi: 10.1371/journal.pmed.1002756

Fig 3. Projected coverage of HPV vaccination in MSM.

Fig 3

The proportion of MSM vaccinated when assuming (A) similar uptake (base-case) or (B) 2-fold increased uptake (improved) as realized for hepatitis B vaccine among MSM, contrasted to the proportion of MSM vaccinated given sex-neutral vaccination in preadolescence, assuming (A) 40% or (B) 80% uptake among 12-year-old boys. In both panels, the combined strategy of vaccination at the age of 12 years with 40% uptake together with a targeted campaign among all MSM with base-case uptake is shown for comparison. HPV, human papillomavirus; MSM, men who have sex with men.